Literature DB >> 8411351

Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.

K Butz1, F Hoppe-Seyler.   

Abstract

The malignant transformation potential of high-risk human papillomaviruses (HPVs) is closely linked to the expression of the viral E6 and E7 genes. To elucidate the molecular mechanisms resulting in HPV oncogene expression, a systematic analysis of the cis-regulatory elements within the HPV type 18 (HPV18) upstream regulatory region (URR) which regulate the activity of the E6/E7 promoter was performed. As the functional behavior of a given cis-regulatory element can be strongly influenced by the overall composition of a transcriptional control region, individual elements were inactivated by site-directed mutagenesis in the physiological context of the complete HPV18 URR. Subsequently, the effects of these mutations on the activity of the E6/E7 promoter were assessed by transient transfection assays. We found that the transcriptional stimulation of the E6/E7 promoter largely depends on the integrity of cis-regulatory elements bound by AP1, SP1, and in certain epithelial cells, KRF-1. In contrast to previous reports by implying a key role for NF1 and Oct-1 recognition motifs in the stimulation of papillomavirus oncogene expression, the inactivation of these elements in the context of the HPV18 URR did not strongly affect the transcriptional activity of the E6/E7 promoter. Mutation of a promoter-proximal glucocorticoid response element completely abolished dexamethasone inducibility of the HPV18 E6/E7 promoter and resulted in an increase of its basal activity. Functional dissection of the HPV18 constitutive enhancer region indicates that its transcriptional activity is largely generated by functional synergism between a centrally located AP1 module and thus far undetected cis-active elements present in the 5' flank of the enhancer. Furthermore, comparative analyses using homologous and heterologous promoters show that the transcriptional activity of HPV18 enhancer elements is influenced by the nature of the test promoter in a cell-type-specific manner.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411351      PMCID: PMC238084     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers.

Authors:  T G Parslow; S D Jones; B Bond; K R Yamamoto
Journal:  Science       Date:  1987-03-20       Impact factor: 47.728

2.  Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens.

Authors:  F Thierry; J M Heard; K Dartmann; M Yaniv
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

3.  A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication.

Authors:  K A Jones; J T Kadonaga; P J Rosenfeld; T J Kelly; R Tjian
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

4.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.

Authors:  E Schwarz; U K Freese; L Gissmann; W Mayer; B Roggenbuck; A Stremlau; H zur Hausen
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Sequence-specific interactions between cellular DNA-binding proteins and the adenovirus origin of DNA replication.

Authors:  P J Rosenfeld; E A O'Neill; R J Wides; T J Kelly
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

8.  Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression.

Authors:  H zur Hausen
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

9.  Characterization of a cell type-specific enhancer found in the human papilloma virus type 18 genome.

Authors:  F V Swift; K Bhat; H B Younghusband; H Hamada
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

10.  Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.

Authors:  T Ishiji; M J Lace; S Parkkinen; R D Anderson; T H Haugen; T P Cripe; J H Xiao; I Davidson; P Chambon; L P Turek
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  44 in total

1.  An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription.

Authors:  I Bouallaga; S Massicard; M Yaniv; F Thierry
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

2.  Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting.

Authors:  P H Bednarek; B J Lee; S Gandhi; E Lee; B Phillips
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

3.  Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.

Authors:  W Zhao; L T Chow; T R Broker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.

Authors:  Vignesh Gunasekharan; Guylaine Haché; Laimonis Laimins
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

6.  Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.

Authors:  Julia Nafz; Johanna De-Castro Arce; Verena Fleig; Andrea Patzelt; Sybille Mazurek; Frank Rösl
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

7.  Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication.

Authors:  Hiroki Isomura; Mark F Stinski; Ayumi Kudoh; Tohru Daikoku; Noriko Shirata; Tatsuya Tsurumi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity.

Authors:  Isabelle Bouallaga; Sébastien Teissier; Moshe Yaniv; Françoise Thierry
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent.

Authors:  Jennifer L Bromberg-White; Ellora Sen; Samina Alam; Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction.

Authors:  Jennifer L Bromberg-White; Craig Meyers
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.